Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   >  Myotonic Dystrophy
>  T-cell Engager Therapy
>  Biclonic® Antibody
  June 2024   e-Newsletter Advertise | Editorial Calendar 
 WuXi Biologics
Latest e-Book
 
  Editorial Calendar
  Author Guidelines
Articles
  Multi-Target Directed Ligands and Lipidomics Approach for...
Traditional medicinal chemistry has focused on single-target drugs, effective for many conditions but inadequate for complex diseases like cancer. Polytherapy tackles this but faces challenges. Multi-Target Directed Ligands (MTDLs) offer a novel approach, targeting multiple disease pathways for enhanced efficacy. Integrating MTDLs with...
  Harnessing Artificial Intelligence...
Artificial Intelligence (AI) is transforming pharmaceutical innovation by accelerating drug discovery and improving drug delivery systems. AI enhances the identification of drug candidates, optimizes formulations, and personalises drug delivery, offering a more efficient and effective approach to drug development. Despite challenges such as data...
kpNext®
News
Junshi Biosciences Gains Approval for sNDA...
Ionis and Otsuka Expand Licensing Agreement...
Techno Trends
 Avidity Biosciences Discovers Novel Delpacibart Etedesiran...
 Amgen Introduces First and Only IMDELLTRA™ T-Cell Engager Therapy...
 Merus Develops Novel Petosemtamab for the Treatment of Head...
Press Releases
Menarini Asia-Pacific partners with...
Singleron Biotechnologies partners with the...
Projects
 Ardena Invests US$25 million (€20 million) to Expand New Facility
 BioHarvest Sciences Invests US$5.5 million (₪20.2 million) to Open...
 AstraZeneca Invests US$1.5 billion for New Manufacturing Facility...
CPHI and PMEC China 2024
Events
24 - 25 June, 2024
European Drug Delivery Summit 2024
25 - 26 June, 2024
Asia Healthcare Week
25 - 27 June, 2024
3rd World ADC Asia
Research Insights
  Parametric Analysis of SARS-CoV-2 Dose-response Models...
 Identification of Circulating miRNAs as Fracture-related Biomarkers
 Targeting of Nanoparticles to the Cerebral Vasculature after Traumatic...
Whitepapers
  A Comprehensive Guide to Responsible AI for Life Sciences
Medical Fair Asia
  Subscribe  |  e-book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.